Syntex' sustained release nicardipine
Executive Summary
The sustained release dosage formulation is being developed in-house. Syntex previously had an agreement with Key but it has been discontinued. "The Pink Sheet" (Dec. 15, p. 11) reported that Key was still developing the product.